What is Amyloidosis?
Most amyloidosis diseases have different treatments; therefore, the correct diagnosis is extremely important.
Featured Patient Story
Making a Difference

Mackenzie Boedicker
Latest Headlines
Efficacy of Acoramidis in Wild-Type and Variant Transthyretin Amyloid CardiomyopathyResults From ATTRibute-CM and Its Open-Label Extension

November 12, 2025
JAMA Cardiol
Published Online: November 8, 2025
Today at the AHA congress in New Orleans, BridgeBio presented data showing that acoramidis significantly reduces all-cause mortality (through month 42) in people living with hereditary ATTR-CM population, with specific benefit noted in those living with...
Calendar & Upcoming Events
Webinar: Simple Digital Tools to Improve Your Patient Journey

Webinar Session: Wednesday, November 19th, 2025 at 6 PM (ET) Zoom Meeting
(These sessions will not be recorded due to patient involvement and HIPAA laws)
To Register HERE
Simple Digital Tools to Improve Your Patient Journey
Speaker: Thomas Bartlett
Webinar: End-of-Life Planning Made Simple

Webinar Session: Wednesday, November 12th, 2025 at 6 PM (ET) Zoom Meeting
(These sessions will not be recorded due to patient involvement and HIPAA laws)
To Register HERE
End-of-Life Planning Made Simple: Choices That Bring Peace of Mind
Speaker: Dr. Stacey Goodman, Vanderbilt University
Webinar: How Clinical Trials are Changing Amyloidosis Treatment

Webinar Session: Wednesday, November 5th, 2025 at 6 PM (ET) Zoom Meeting
(These sessions will not be recorded due to patient involvement and HIPAA laws)
To Register HERE
How Clinical Trials are Changing Amyloidosis Treatment
Speaker: Dr. Rodney Falk, Cardiologist Brigham Women’s Hospital
Amyloidosis Videos
Featured Product
Gray Run Shirt








